Director/PDMR Shareholding

RNS Number : 6735N

GlaxoSmithKline PLC

27 October 2016

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Sir Andrew Witty
b)	Position/status	Chief Executive Officer
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Sale of 10,000 Ordinary Shares on 27 October 2016 at a price of £16.365.
c)	Price(s) and volume(s)	Price(s) Volume(s) £16.365 10,000
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2016-10-27
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHQDLFLQBFXFBD